INS and Alzheimer disease: The expression of miR-7 is increased in the brains of patients with Alzheimer’s disease (AD) and with resistance to insulin, as it targets crucial regulators of insulin homeostasis [121] and also key cholesterol biosynthesis elements essential for forming lipid rafts [122].